Recurrence: all 3,523 studies

Page 20 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and RecurrenceStatus unknownNCT04758455Not applicable
• Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaActive, not recruitingNCT04756726Phase 1
• Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDSStatus unknownNCT04749355Phase 2
• Mogamulizumab Q4week Dosing in Participants With R/R CTCLActive, not recruitingNCT04745234Phase 2
• The Effects of the Be Mindful Intervention in Previously Depressed Individuals Experiencing Subclinical SymptomsCompletedNCT04740879Not applicable
• Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic StrokeCompletedNCT04738097Phase 3
• A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory MyelomaTerminatedNCT04735575Phase 1/2
• High Concentration Oxygen for Pneumocephalus After Evacuation of Chronic Subdural HaematomaStatus unknownNCT04725851Not applicable
• Dual Target CAR-T Cells in B-cell LymphomaStatus unknownNCT04723914Phase 1/2
• Dual Target CAR-T Cells in B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT04723901Phase 1/2
• Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological MarkersCompletedNCT04723121Not applicable
• PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AMLStatus unknownNCT04722952Phase 3
• Lyon PJI Retrospective Cohort StudyStatus unknownNCT04722926
• Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)CompletedNCT04721002
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell LymphomaActive, not recruitingNCT04718883Phase 2
• OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OCActive, not recruitingNCT04713514Phase 2
• Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic SyndromeStatus unknownNCT04713410Not applicable
• Recurrent S. Aureus Infections in Osteoarticular InfectionsStatus unknownNCT04712123
• A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular LymphomaActive, not recruitingNCT04712097Phase 3
• Novel BCMA-targeted CAR-T Cell Therapy for Multiple MyelomaStatus unknownNCT04706936Phase 1
• Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaNo longer availableNCT04705454
• Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT04699162
• Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHLActive, not recruitingNCT04697940Phase 1/2
• Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-respondersCompletedNCT04695769Phase 4
• A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) MutationCompletedNCT04691648
• BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALLActive, not recruitingNCT04690595Phase 1
• Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/LymphomaCompletedNCT04689659Phase 2
• This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04689308Phase 1
• SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological MalignanciesActive, not recruitingNCT04684108Phase 1
• A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical CancerCompletedNCT04680988Phase 2
• Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCTTerminatedNCT04679194Phase 1
• Flotetuzumab Expanded Access ProgramNo longer availableNCT04678466
• CD123 Redirected T Cells for AML in Pediatric SubjectsTerminatedNCT04678336Phase 1
• To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550TerminatedNCT04674748Phase 1
• Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute LeukemiaStatus unknownNCT04674345Phase 2/3
• TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-ThyrosineActive, not recruitingNCT04671459Phase 2
• HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their CaregiversCompletedNCT04670016
• Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the BreastStatus unknownNCT04666805
• A Prognostic Model to PREDICT Relapse of Depression in Primary CareCompletedNCT04666662
• Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)CompletedNCT04666649Phase 1
• Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus RelapseStatus unknownNCT04662138
• Analgesia aNd caNcer recUrrence Lung cAncer ResectionCompletedNCT04656769
• AB154 Combined With AB122 for Recurrent GlioblastomaActive, not recruitingNCT04656535Early Phase 1
• HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialCompletedNCT04653818Phase 4
• A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With MelanomaTerminatedNCT04653038Phase 1
• Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center StudyStatus unknownNCT04640363
• The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the LungCompletedNCT04634630
• Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin LymphomaStatus unknownNCT04626908Phase 1/2
• CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple MyelomaStatus unknownNCT04626752Early Phase 1
• A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical CancerStatus unknownNCT04623333Phase 2
• First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue SarcomaCompletedNCT04619056Phase 1
• The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and ProgressionCompletedNCT04617743
• Stability of Maxillary Anterior Teeth After Two Years of Retention in Adolescents Comparing Two Bonded and a Vacuum-formed RetainerCompletedNCT04616755Not applicable
• Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT04613557Phase 1
• Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive BronchitisStatus unknownNCT04613180Phase 4
• Axi-cel in CNS LymphomaActive, not recruitingNCT04608487Phase 1
• Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)WithdrawnNCT04607772Phase 1/2
• The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.CompletedNCT04603612Not applicable
• A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific MarkersTerminatedNCT04603040Phase 2
• NK Cell Therapy Recurrent/Refractory Elderly AMLStatus unknownNCT04599452Phase 1/2
• Recurrence After Whipple's (RAW) StudyCompletedNCT04596865
• Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or ParagangliomaCompletedNCT04573816
• Representational Approach to Hippocampal Functions : a fMRI StudyCompletedNCT04562974Not applicable
• NPC - AXEL Study : Axitinib-AvelumabCompletedNCT04562441Phase 2
• To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian CancerWithdrawnNCT04561817Phase 2
• TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)CompletedNCT04557436Phase 1
• Relapse Prevention in Stimulant Use DisorderWithdrawnNCT04553263Early Phase 1
• Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic LymphohistiocytosisActive, not recruitingNCT04551131Phase 1/2
• Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable
• A Feasibility Study on the Value of Pelvic Floor Training After Pelvic Organ Prolapse SurgeryStatus unknownNCT04539782Not applicable
• Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.Status unknownNCT04539665Not applicable
• A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell LymphomaCompletedNCT04539444Phase 2
• Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RDStatus unknownNCT04539197
• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Active, not recruitingNCT04534205Phase 2/3
• AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung CancerTerminatedNCT04525391Phase 2
• A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLActive, not recruitingNCT04521231Phase 1/2
• The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSATerminatedNCT04519489Not applicable
• Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid LeukemiaCompletedNCT04512105Phase 1
• Naxitamab and GM-CSF in People With NeuroblastomaNo longer availableNCT04501757
• Outcomes of Patients With Diverticulitis and Risk Factors for RecurrenceCompletedNCT04500405
• Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 MutationStatus unknownNCT04489706Not applicable
• Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of CholedocholithiasisCompletedNCT04484870Phase 4
• Peer-delivered and Technology-Assisted Integrated Illness Management and RecoveryCompletedNCT04481737Not applicable
• A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDSTerminatedNCT04477291Phase 1
• Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCLStatus unknownNCT04476459Phase 1/2
• Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating FieldsActive, not recruitingNCT04469075Phase 2
• Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
• A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory LymphomasTerminatedNCT04464798Phase 1
• Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)WithdrawnNCT04456023Phase 2
• A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaActive, not recruitingNCT04442022Phase 2/3
• Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric CancerCompletedNCT04439812
• A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSLStatus unknownNCT04438044Phase 2
• A Study of ICP-022 in Patients With R/R DLBCLCompletedNCT04438005Phase 2
• A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT04434196Phase 1
• Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid CancerActive, not recruitingNCT04420754Phase 1
• Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)Active, not recruitingNCT04416984Phase 1/2
• Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell TherapyCompletedNCT04409314
• REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive TherapyTerminatedNCT04409080Phase 1
• Prospective and Multicentre Study on Clinical-biological Factors Predictive of Chronic Colon DIverticulitisStatus unknownNCT04407793
• Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical CancerCompletedNCT04405349Phase 2

← Recurrence overview